September 19, 2014 10:16 PM ET


Company Overview of Gryphon Therapeutics, Inc.

Company Overview

Gryphon Therapeutics, Inc. went out of business. Gryphon Therapeutics, Inc. develops polymer-modified proteins made by chemical synthesis. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics, Inc. was formerly known as Gryphon Sciences and changed its name in October, 2002. The company was founded in 1993 and is based in South San Francisco, California.

600 Gateway Boulevard

South San Francisco, CA 94080

United States

Founded in 1993





Key Executives for Gryphon Therapeutics, Inc.

Gryphon Therapeutics, Inc. does not have any Key Executives recorded.

Gryphon Therapeutics, Inc. Key Developments

Gryphon Announces General Availability of Core Voice(TM)

Gryphon announced the general availability of Core Voice(TM), a comprehensive call recording and business intelligence service that captures voice conversations in real time, from any phone used to conduct business. With Core Voice, businesses can retain important, customer-related voice conversations from any sales or service agents throughout the enterprise. These recordings are often necessary for audit purposes, but also provide advanced monitoring and analytic capabilities, so managers can gain better insight into sales activity and marketing effectiveness. Agents can access Core Voice through a variety of methods, such as through their office phones, through their CRM using click-to-dial, by dialing a 1-800 access and using an assigned PIN number, and even from their mobile phones through a smartphone dialer app. Core Voice provides 100% guaranteed compliance with Do-Not-Call and other marketing privacy regulations and is indemnified by Gryphon. It also offers:- Target(TM) Speech Analytics: Core Voice automatically aggregates relevant voice interactions - wireless, landline, or VoIP - and delivers practical scores to determine the 'sales effectiveness' and 'script compliance' of each call, based on company-specific key performance indicators (KPIs). Target Speech Analytics can also deliver interpretations based on relationships, similarities, and patterns to detect emerging trends or opportunities. Key Phrase and Emotion Alerts: Proactive emails can be sent when Core Voice identifies important words or phrases used during conversations. It can also send alerts based on irritation, anger, or happiness, which allows monitoring of user responses as well as agent inquiry; Agent-Initiated Recording: Agents can use in-call disposition keys to initiate and terminate portions of a conversation, for documented consent or follow-up.

Similar Private Companies By Industry

Company Name Region
Acetylon Pharmaceuticals, Inc. United States
Receptor Logic, Inc. United States
Russ Pharmaceuticals United States
Makefield Therapeutics Inc. United States
OMJ Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Gryphon Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at